Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

Clinical trial NCT06075264 · RECRUITING

Trial details

NCT number: NCT06075264
Sponsor: Frantz Viral Therapeutics, LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Vulvar Diseases HPV Infection Vulvar HSIL Pre-Cancerous Dysplasia HPV Disease VIN, Usual Type VIN 2 of Usual Type VIN 3 of Usual Type Vin II Vin III VIN Grade 2 VIN Grade 3

Start date: 2023-12-06
Primary completion: 2026-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.